Advanced Filters
noise

Washington, District of Columbia Clinical Trials

A listing of Washington, District of Columbia clinical trials actively recruiting patient volunteers.

Found 1,519 clinical trials
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Men at High Genetic Risk for Prostate Cancer

Background Research studies have shown that genetic changes and family history may increase a man s risk for prostate cancer. Researchers want to follow the prostate health of men who have specific genetic changes associated with prostate cancer to help them learn more about which men are at higher risk …

30 - 75 years of age Male Phase N/A
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Tumor Related Epilepsy

Background Some people with brain tumors have seizures related to the tumor. This is called tumor-related epilepsy. Usually brain tumors are treated by removing as much of the brain tumor as possible without causing problems. Researchers think this may improve the outcome for people with brain tumors. It may completely …

8 - 99 years of age All Phase N/A
A Amy Nelson, MA, CCRC

Post-Market Study to Assess iTind Safety in Comparison to UroLift

The study objective is to evaluate the safety of the iTind device comparied to UroLift.

50 years of age Male Phase N/A
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

Background Certain blood cancers can be treated with blood or bone marrow transplants. Sometimes the donor cells attack the recipient's body, called graft-versus-host disease (GVHD). The chemotherapy drug cyclophosphamide helps reduce the risk and severity of GVHD. Researchers want to learn if using a lower dose of cyclophosphamide may reduce …

12 - 85 years of age All Phase 1/2
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Data Collection of Standard Care of Patients in the EMG Section

Background Most people who are referred to the EMG (Electromyography) Section of the NIH are enrolled into specific active studies. This allows researchers to learn about a range of rare neuromuscular disorders. But study criteria may not give researchers the chance to evaluate a single person or study a common …

18 - 110 years of age All Phase N/A

Natural History of KSHV-Associated Multicentric Castleman s Disease

Background Kaposi s sarcoma herpes virus (KSHV) causes several kinds of cancer, Kaposi sarcoma (KS), a form of Multicentric Castleman s Disease (MCD) and a type of lymphoma known as Primary Effusion Lymphoma (PEL). These cancers can occur alone or at the same time in the same patient. MCD can …

18 years of age All Phase N/A

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

Background \- Lymphangioleiomyomatosis (LAM) is a rare type of lung disease that occurs almost exclusively in women. In LAM, muscle tissue grows in the lungs and starts to block the flow of air. It is a progressive disease, and in severe cases may require a lung transplant. One possible treatment …

18 - 100 years of age Female Phase 1/2
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Development of a Wearable Point of Care Monitoring Device for Pediatric Obstructive Sleep Apnea

Background Obstructive sleep apnea (OSA) occurs when the blockage of the airway causes a person to stop breathing involuntarily for 10 seconds or more throughout the night during sleep. Pediatric OSA can be especially concerning and can have long-term effects. Researchers want to see how a monitoring device called near-infrared …

3 - 12 years of age All Phase N/A
K Keri Toner, MD

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

This Phase I dose-escalation trial is designed to evaluate the safety of administering rapidly -generated tumor multi-antigen associated -specific cytotoxic T lymphocytes, to HSCT recipients with high risk AML and MDS.

6 - 80 years of age All Phase 1
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)

Background People with familial partial lipodystrophy (FPLD) do not store fat in the body normally. This can lead to serious illnesses such as diabetes and heart disease. To learn more about FPLD, researchers want to compare the fat tissue in people with this disease to the fat tissue of healthy …

18 - 65 years of age All Phase N/A

Simplify language using AI